FY 2024 conference call to be held on March 20, at 8:00 a.m. Eastern Time
HONG KONG, March 13, 2025 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", stock code: 1696.HK; together with its subsidiaries referred as the "Group"), a global consumer wellness group featuring a first-of-its-kind synergistic ecosystem of business building blocks and consumer-focused brands, emphasizing on energy-based devices and injectables, alongside other complementary offerings, today announced that it expects to release its financial results for FY 2024, ended December 31, on Wednesday, March 19, 2024.
Sisram's management team will host a conference call to discuss the financial results on Thursday, March 20, 2024, at 8:00 a.m. Eastern Time.
Speakers will include Mr. Liu Yi, Sisram's Chairman, Mr. Lior Dayan, Sisram's Chief Executive Officer, Mr. Jiahong LI, Sisram's CFO, Mr. Doron Yannai, Alma's CFO, and Ms. Qianli Fang, Sisram's Secretary of the Board. Following the prepared remarks, management will be available for a question-and-answer session.
please register in advance for the webinar using the following link:
After registering, you will receive a confirmation email with instructions for joining the webinar.
The conference call will begin at:
8:00 a.m. Eastern Time
5:00 a.m. Pacific Time
2:00 p.m. Israel Time
A replay will also be available on Sisram Medical's IR Events & Presentations page.
About Sisram Medical Ltd
Sisram Medical Ltd (1696.HK) is a global consumer wellness group, featuring a first-of-its-kind synergistic ecosystem of business building blocks and consumer-focused branding, emphasizing on energy-based devices and injectables, alongside other complementary offerings. The Company is majority owned by Fosun Pharma, one of China's leading healthcare groups. On September 19, 2017, Sisram Medical went public on the Main Board of the Hong Kong Exchange.
Sisram Medical – Enhancing Quality of Life